Acquisition Completed

Eli Lilly and Company acquisition of 4E Therapeutics

Announced 16 Jun 2026

Advisers

4E Therapeutics

Target

Financial adviser
Aquilo Partners LP

Eli Lilly and Company

Acquirer

Not disclosed

Target
4E Therapeutics
Acquirer
Eli Lilly and Company
Target based in
United States
Buyer based in
United States
Completed
16 Jun 2026
Sector
Biotech
Tags
Biotech, Drug Development

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.